Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome
Clinical Endocrinology Mar 20, 2019
Le MT, et al. - In this multicentre cross-sectional descriptive study, which included 863 infertile women (aged 18 to 45 years), researchers investigated the role of anti-Mullerian hormone (AMH) and LH/FSH ratio in the diagnosis of polycystic ovary syndrome (PCOS). With the AUC 0.852, AMH showed sensitivity and specificity of 78.50% and 75.83% respectively at an optimum cut-off level of 32.79 pmol/L. In the diagnosis of PCOS, the value of serum AMH concentration was found not significantly higher than the LH/FSH ratio. Although these biomarkers are not adequate separately for the diagnosis of PCOS based on their own value, the combination of various endocrine factors including AMH, LH and LH / FSH ratio together with BMI and other anthropometric and clinical characteristics may provide extra value for the diagnosis of PCOS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries